In life sciences, patients always come first. With standard service level targets of 99% and more, decision makers have long settled for huge stock levels, focusing on product availability over manufacturing efficiency, operating margins, and cost. Next gen planning solutions now reconcile top service levels with profit optimization.
In addition to end-to-end visibility throughout the value chain, OMP for Life Sciences intelligently adjusts production, packaging, and distribution lines, capacities, and networks. All this while optimizing inventory levels of intermediate and finished products as well as synchronizing manufacturing equipment and packaging lines.
The availability of capacity constraint solvers, in combination with self-learning data, advanced data management, and integration features, all guarantee a perfect sync between plan and reality, making planning outcomes both realistic and feasible. Decision-makers can react faster and with greater precision to unexpected disruptions in demand and supply, improving responsiveness and managing risk.
But OMP for Life Sciences has even more to offer. Its attribute-based planning options, for example, allow decision-makers to plan for specific batch characteristics and shelf life requirements, instead of planning on materials alone.
Pegging functionality lets you peg any demand and supply element according to the various rules integrated within the model, including regulatory constraints, quantity tolerance, and shelf-life. Pegging can also be applied retroactively by tracing and recording the origin of every batch produced, providing end-to-end visibility over internal and external networks, from the drug substance and its components to the demand.
AI, solvers, ML, and data science can all be used to assess the impact of predicted or unexpected demand shocks, supply disruptions, batch contamination, production incidents, packaging errors, and logistics issues. They can also support you in developing and evaluating smart alternative solutions and scenarios to better anticipate or respond to such events.
Avanos Medical, Inc., a leading medical devices company, started using Unison PlanningTM with SAP S/4HANA. Using OMP for Life Sciences, Avanos has improved its planning maturity and E2E supply chain visibility successfully.Read the news
How can Unison Planning™ create additional value for every stakeholder? Here’s how one world leader in pharmaceuticals is making full use of OMP’s signature solution to deliver exactly that, as part of a major transformative business journey.Read case study
To stay ahead of the curve, we participate in important supply chain events worldwide like LogiPharma, the world’s leading pharma supply chain event. It’s a great place to network, share expertise and gather new knowledge.
We know exactly how a fragmented and unpredictable demand puts pressure on production and distribution processes. Meet the experts.
Roche, a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives and the world’s largest biotech company, has begun implementing OMP as its supply chain planning system of record (SOR) in the pharmaceutical division.Read the news
UCB has rolled out a full-scope OMP planning solution to ensure end-to-end visibility of their global supply chain. This integrated solution covers all supply chain planning functions: demand planning, executive S&OP, S&OP, inventory optimization, MPS, DRP, deployment, detailed scheduling and transport planning.Read the news
More and more companies are investing in sustainability, and there’s a good reason for that: climate change is one of the biggest issues facing humanity and we’re already seeing the consequences, with increasingly severe floods, forest fires, shrinking ice caps, record temperatures and deadly droughts.Read the blog
Stef Vermeiren, Vice President Global Planning – Janssen Pharmaceutica at Johnson & Johnson
David Aherne, Senior Director Global Supply Chain at Alexion Pharmaceuticals